Trial Outcomes & Findings for A Long Term Follow up of Anterior Meshes for Recurrent Prolapse (NCT NCT02642835)
NCT ID: NCT02642835
Last Updated: 2018-05-29
Results Overview
clinic visit. 5 patients were interviewed by phone and were not examined - hence this figure is out of 43 not 48.
COMPLETED
48 participants
1 hour
2018-05-29
Participant Flow
Participant milestones
| Measure |
Mesh Group
all had an anterior mesh for recurrent prolapse
|
|---|---|
|
Overall Study
STARTED
|
48
|
|
Overall Study
COMPLETED
|
48
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
A Long Term Follow up of Anterior Meshes for Recurrent Prolapse
Baseline characteristics by cohort
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Age, Continuous
|
66 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
48 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
BMI
|
27.4 wt kg/ht m squared
n=5 Participants
|
|
Parity
|
2 vaginal deliveries past 28 weeks
n=5 Participants
|
|
time to follow up (months)
|
82 number of months
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 hourclinic visit. 5 patients were interviewed by phone and were not examined - hence this figure is out of 43 not 48.
Outcome measures
| Measure |
Mesh Group
n=43 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
The Number of Participants With a Current Mesh Erosion or Treated for a Mesh Erosion Since Inserted
|
5 Participants
|
SECONDARY outcome
Timeframe: 1 hourThe presence of less than stage 2 prolapse (eg stage 1) anterior wall prolapse determined as anatomical success. A stage one prolapse is higher than 1cm above the vaginal entrance. A stage 2 prolapse means that the leading edge of the prolapse is between 1cm above the entrance to the vagina up to 1cm below the entrance to the vagina.
Outcome measures
| Measure |
Mesh Group
n=43 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants With no Physical Evidence of Recurrent Prolapse as Determined by Physical Examination
|
26 Participants
|
SECONDARY outcome
Timeframe: 1 hourEfficacy determined by the question in the pelvic floor prolapse distress inventory "usually have a bulge or something falling out that you can see or feel in your vaginal area". Determined at clinic visit by questioning
Outcome measures
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants Complaining of a Bulge. Recurrent Prolapse
|
14 Participants
|
SECONDARY outcome
Timeframe: 1 hourclinic visit; number of participants who underwent reoperation of recurrent prolapse in the same compartment
Outcome measures
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants Requiring Treatment for Recurrent Prolapse - Prolapse in the Same Part of the Vagina
|
1 Participants
|
SECONDARY outcome
Timeframe: 1 hourThis is where the mesh has held up and there is no prolapse where it was inserted. This measure refers to when a different part of the vagina has prolapsed.
Outcome measures
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants Who Underwent Reoperation for Prolapse in a Different Compartment
|
8 Participants
|
SECONDARY outcome
Timeframe: 1 hourThe mesh has caused the prolapse to be successfully repaired but the patient has developed stress incontinence as a separate issue. clinic visit
Outcome measures
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants Who Developed New Stress Incontinence
|
5 Participants
|
SECONDARY outcome
Timeframe: 1 hourThe patient global impression of Improvement scale (PGI-I) is a global improvement scale filled out by the patient. It is graded as very much better, much better, a little better. no change, a little worse, much worse or very much worse.clinic visit
Outcome measures
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants Who Rated Their Improvement as Better or Very Much Better
|
33 Participants
|
SECONDARY outcome
Timeframe: 1 hourA mesh erosion is when the body rejects the mesh and it is visible in the vagina rather than being buried under the vaginal epithelium. clinic visit
Outcome measures
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants Who Needed Surgical Mesh Removal for Erosion
|
2 Participants
|
SECONDARY outcome
Timeframe: 1 hourpatients may develop pain after the original operation which needs a second surgical procedure to try and help. clinic visit
Outcome measures
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants Who Needed Reoperations for Pain
|
3 Participants
|
SECONDARY outcome
Timeframe: 1 hourThis records any problems that were encountered at the original insertion of the mesh. clinic visit
Outcome measures
| Measure |
Mesh Group
n=48 Participants
underwent anterior mesh for recurrent cystocele
|
|---|---|
|
Number of Participants Who Experienced Intraoperative Complications
|
0 Participants
|
Adverse Events
Mesh Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Professor Jonaathan Duckett -Consultant Urogynaecologist
Medway NHS Foundation Trust
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place